Aris Baras

Aris Baras is the SVP of Regeneron Genetics Center at Regeneron. Aris has over 15 years of experience in the biotech and pharmaceutical industries. Aris started their career as a consultant for Liquidia Technologies from January 2007 to December 2011 where they focused on R&D Strategy and Business Development. In August 2004, Aris started working at Duke University Medical Center as a Biomedical Research conducting research in the Haystead Lab for Pharmacology & Cancer Biology from 2011-2012, the Tedder Lab for Immunology from 2005-2006, and the Lyerly/Devi Lab for Cancer Center from 2004-2006.

Aris Baras received their BS in Biology and Economics from Duke University. Aris then went on to receive their MBA from Duke University's Fuqua School of Business with a Health Sector Management Certificate. Finally, they completed their MD at Duke University School of Medicine.

Aris Baras reports to Neil Stahl, EVP, R&D. They are on a team with Gary Herman - SVP, Early Clinical Development & Experimental Sciences, David Weinreich - SVP Global Clinical Development, and John Lin - SVP, Immuno-Oncology & Head of Bispecifics.